Health CanadaGeneral Alert
KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndro...
Published: March 20, 2017Recall ID: 56351Category: generalCountry: Canada
Product Description & Identification
KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 56351 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/keytruda-pembrolizumab-risk-severe-skin-reactions-stevens-johnson-syndrome-and-toxic |
| Title | KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2017-03-20 |
| Organization | Marketed health products |